Discontinued — last reported Q4 '25

Eli Lilly EPS (Basic) increased by 19.1% to $7.41 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 51.2%, from $4.90 to $7.41. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows an upward trend with a 39.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2007
Last reportedQ4 2025

How to read this metric

Higher values indicate more value is being generated for each individual share held.

Detailed definition

The portion of a company's profit allocated to each outstanding share of common stock, calculated using the actual numbe...

Peer comparison

This is a standard benchmark used to compare the earnings power of companies regardless of their total size or market capitalization.

Metric ID: is_eps_basic

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$1.53$1.22$1.91$2.11$1.06$1.61$2.15$1.49$1.96-$0.06$2.43$2.49$3.29$1.08$4.90$3.07$6.30$6.22$7.41
QoQ Change-20.3%+56.6%+10.5%-49.8%+51.9%+33.5%-30.7%+31.5%-103.1%>999%+2.5%+32.1%-67.2%+353.7%-37.3%+105.2%-1.3%+19.1%
YoY Change-30.7%+32.0%+12.6%-29.4%+84.9%-103.7%+13.0%+67.1%+67.9%>999%+101.6%+23.3%+91.5%+475.9%+51.2%
Range-$0.06$7.41
CAGR+42.0%
Avg YoY Growth+183.8%
Median YoY Growth+51.2%

Frequently Asked Questions

What is Eli Lilly's eps (basic)?
Eli Lilly (LLY) reported eps (basic) of $7.41 in Q4 2025.
How has Eli Lilly's eps (basic) changed year-over-year?
Eli Lilly's eps (basic) increased by 51.2% year-over-year, from $4.90 to $7.41.
What is the long-term trend for Eli Lilly's eps (basic)?
Over 4 years (2021 to 2025), Eli Lilly's eps (basic) has grown at a 39.1% compound annual growth rate (CAGR), from $6.15 to $23.00.
What does eps (basic) mean?
The amount of profit earned for every single share of stock currently owned by investors.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.